The RESOURCE page currently has links to historical material in the area of ETHICS, EVALUATION, and ARTICLES. These resource have been on PHII’s web site since its inception. The three areas are: Ethics, Evaluation, and Articles, all of which remain relevant.
An internal ad hoc committee co-chaired by Mary Madison, PHII Board member, and Gary Montrose, co-founder of the PHII, has been formed and provides these recommended links to external and credible resources regarding comparative effectiveness research. The PHII believes that all “research” must be compared to something (i.e. a refernet) therefore, in the broadest sense we are advocates for sound, valid, and transparent comparative effectiveness research & analysis.
Comparative Effectiveness Research
Federal Agencies Funding Comparative Effectiveness Research- ARRA (American Recovery and Reinvestment Act)
- AHRQ: Allocated $300 million
- HHS: Allocated $400 million to award to organizations studying Comparative Effectiveness
- NIH: Allocated $400 million
*The amounts cited in this section were provided by this link to the ARRA
Policy/Institutes for Comparative Effectiveness Research
- The Commonwealth Fund’s Commission on a High Performance Health System
- National Health Policy Forum
- Brookings Institute
- Rand Corporation
- Institute of Medicine
- National Institute for Health and Clinical Excellence (NICE)
- Academy of Managed Care Pharmacies
Research Organizations/Aggregators
- The Lewin Group
- The Foundation for Informed Medical Decisions
- ECRI Institute
- Center for Reviews and Dissemination
- Blue Cross Blue Shield Technology Evaluation Center
Associations Supporting CER
Foundations Supporting CER
Consumer Information Services
- Prescription for Change
- CBO / Paper on the CE of Medical Treatments
- AARP
- Consumer Reports
- Chamber of Commerce, report on Comparative Effectiveness
- Cost Effectiveness Analysis (CEA) Registry
- The Cochrane Collaboration
- Drug Effectiveness Review Project (DERP)
- National Institute for Health Research, Health Technology Assessment Program
“Emerging Players”